Lab Automation Market

Global Lab Automation Market Size (2023 to 2028)

The global market size for lab automation is estimated to grow at a CAGR of 7.78% from 2023 to 2028. As a result, the market is predicted to value USD 9.46 billion by 2028 from USD 6.5 billion in 2023.

Laboratory automation is the integration of automated technologies into the laboratory to enable new and improved processes by eliminating the most repetitive tasks like preparing libraries, which can be done by use of advanced technologies in the labs, enabling even the entire workflow to be automated. The main benefits of lab automation are efficiency, Reproducibility, safety, data accuracy, traceability, and faster translation.

Impact of COVID-19 on the global lab automation market:

The COVID-19 pandemic has positively impacted the global lab automation market due to additional pressure on laboratories for high testing speed and increased capacity. As a result, R%D in this area has seen an increase in the development of automation system suppliers with an increase in the number of samples evaluated daily due to the rise in several daily cases, which is projected to generate chances for the expansion of the lab automation market.

MARKET DRIVERS:

Factors such as increased reproducibility and accuracy, high demand for labor and a gap of supply, advancements in drug discovery and clinical diagnostics, increased productivity, and reduced costs propel the lab automation market.

Data accuracy is another aspect that is improved through lab automation since it accurately helps to differentiate a potential pathogen from a contaminating microbiota. Traceability helps compare test results and data provenance for describing the history and origin of data. These labs provide Security with protocols for handling hazardous chemicals and machinery, reducing risks for researchers and technicians. In addition, the option of faster translation reduces the time needed to translate results. Although cost-cutting measures may have served as the original impetus, chances to shorten lead times and improve reproducibility, quality, and safety are now more apparent, driving the growth of the worldwide lab automation market.

Miniaturization of processes to further augment the lab automation market growth.

The rise in demand for miniaturization is another factor expected to influence the expansion of the lab automation market. Resources and workforce are often stretched to the absolute limit in today's busy labs and ought to improve throughput, efficiency, and quality. Therefore, biotechnology, microbiology, and clinical chemistry facilitate the miniaturization of the investigation processes with the end of the imagination of solutions.

Automation can improve output quality by reducing operator-induced variability and contamination. It can allow a higher rate of experimental data entry, use a broader range of controls, give a greater volume of results, and reduce preanalytical errors like mislabeling or misplacement of specimens. According to a report, 70% of scientists have tried and failed to replicate the experiments, making Reproducibility a significant concern, which is easily provided by automation.

MARKET RESTRAINTS:

The major factors restraining the growth of the global lab automation market due to lack of flexibility for high-throughput screening, the need for flexibility in drug discovery, the need to manage complex testing, and time-consuming sample preparation, financial constraints, high cost of running a high-performance scan, difficulty in labs for changing their tests multiple times, and one-time specific assessment. Due to the high maintenance and service expenses involved with laboratory systems, many small and medium-sized labs find it challenging to invest in automation, which is also a significant barrier to the growth of the lab automation market.

REPORT COVERAGE:

This research report on the global lab automation market has been segmented and sub-segmented based on the equipment and software, application, end-user & region.

Global Lab Automation Market – By Equipment and Software:

• Automated Clinical Laboratory Systems
  • Workstations
  • LIMS (Laboratory Information Management Systems)
  • Sample Transport Systems
  • Specimen Handling Systems
  • Storage Retrieval Systems
• Automated Drug Discovery Laboratory Systems
  • Plate Readers
  • Automated Liquid Handling Systems
  • Robotic Systems
  • Storage Retrieval Systems
  • Dissolution Testing Systems

Based on the equipment and software, the automated clinical laboratory systems segment had a significant share of the lab automation market in 2022. Due to the many advantages of using an automated analyzer, such as the minimum amount of sample used, less risk of human error with high accuracy and reproducibility in the lab, and much more, the automated clinical laboratory systems segment is expected to dominate the market. The most used among these is LIMS for tracking instrumentation, experiments, and sample data, which offers the ability to improve workflow.

On the other hand, the automated drug discovery laboratory systems segment is anticipated to grow at a healthy CAGR during the forecast period owing to their ability to provide more consistent data and enable labs to make faster and better decisions.

Global Lab Automation Market – By Application:

• Life Sciences Research and Development
• Drug Discovery
• Clinical Diagnostics

Based on the application, the clinical diagnostics segment is anticipated to lead the market during the forecast period. Leveraging automation in clinical labs has the potential to improve and accelerate clinical diagnostics is one area for improved patient quality of life, including survival chances, which is the reason for this segment to dominate the market.

The drug discovery segment is also estimated to register a healthy CAGR during the forecast period owing to the requirement of developing new medicines to continue chosen lifestyles and prevent death due to diseases.

Global Lab Automation Market – By End-User:

• Clinical Chemistry Analysis
• Photometry & Fluorometry
• Immunoassay Analysis
• Electrolyte Analysis

Based on the end-user, the clinical chemistry analysis segment is anticipated to project a high CAGR during the forecast period owing to automation in the clinical laboratory used to perform laboratory tests, along with processing, transporting, loading, evaluating, and storing archive samples.

On the other hand, the photometry and fluorometry segment is anticipated to account for a substantial share of the lab automation market over the forecast period. Photometry and fluorometry are widely accepted and powerful techniques for DNA sequencing and genetic analysis and are used in diagnostic, medical, and forensic applications. In addition, photometry is used for general analytical chemical literature, and Fluorometry is used for quantitative analytics in chemical and biological sciences.

Global Lab Automation Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Geographically, the North American region had the most significant share of the global market in 2022 and is forecasted to showcase domination in the global market throughout the forecast period owing to the rapid diagnostic systems development, presence of major pharmaceutical companies, clinics, and blood banks developments, increasing investment in the drug discovery and genomics market, and rapid automation of laboratory instruments in hospitals. Moreover, the presence of many advanced healthcare institutions and pharmaceutical companies, increasing expenditure on modernization, many vendors in the region, and a favorable reimbursement framework are propelling the lab automation market in the North American region.

The European region accounted for a substantial global market share in 2022. The adoption of laboratory automation systems owing to the massive applications in the biotech and pharma industry, clinical diagnostics, and drug discovery, would collectively capture a lucrative share of the European region. In addition, rising R&D initiatives by governmental and non-governmental entities and prospects for automation growth in France, Germany, and the UK, are poised to generate new income ecosystems in the market.

The region of Asia-Pacific is also expected to grow at the highest CAGR over the forecast period owing to the increasing number of partnerships, higher growth rates of molecular diagnostic tests, increasing digitization of healthcare, and improvements in quality are the critical factors for the laboratory automation market. In addition, most medical device manufacturing companies focus on creating automated devices with the benefits of research with modern facilities and strengthening software in vitro diagnostics, which would further implicitly boost the growth of the lab automation market.

The Latin America, Middle East, and African regions are expected to show a moderate growth rate due to increased throughput at a remarkable rate, high disease burden, precise movements, consistent reporting, and increasing availability of health insurance. In addition, the demand for automated devices, software, and advanced services has tripled since the advent of automation techniques due to the enormous volume of diagnostic cases and real-time outcomes analysis. Thus, the demand for laboratory automation in extensive integrated healthcare systems will be driven by the abovementioned elements.

KEY MARKET PARTICIPANTS:

Some of the noteworthy companies in the global lab automation market profiled in this report are PerkinElmer, Danaher, Thermo Fisher, Agilent Technologies, Hamilton Robotics, Abbot Diagnostics, Eppendorf, QIAGEN, Roche Diagnostics, Siemens Healthineers, BMG Labtech GmbH, Aurora Biomed Inc. and Hudson Robotics.

RECENT HAPPENINGS IN THIS MARKET:

• In October 2022, Vyripharm Enterprises Inc., a Texas biopharmaceutical/biotechnology company and a leading global technology company, ABB Robotics, signed for developing an automated laboratory testing platform to enable quality control of raw materials, certification of analyzed samples, and to support data capture for new pharmaceutical compounds.
• In October 2022, Syntegon extended the Automated Process Development (APD) tool for capsule filling to tablet presses to help pharmaceutical manufacturers determine the ideal process parameters for every product before transferring them to production machinery.